Outcomes for hospital length of stay, 30-day mortality, 30-day graft loss similar for nucleic acid test-positive and -negative donors
Wait Times for Pediatric Heart Transplants Longer During Pandemic
Despite longer waiting list times, graft and recipient survival maintained and waiting list mortality unchanged
Drop Seen in Transplantation in 2020 With COVID-19 Pandemic
Decrease noted in transplants and in waitlist registrations for transplants compared with those expected
AUA: Kidney Transplants From COVID-19-Infected Donors Are Safe
Recipient outcomes similar to kidneys from noninfected donors
Vaccination Cuts Severe COVID-19 Risk in Heart Transplant Patients
COVID-19 vaccination is not associated with heart transplant-specific adverse events
Survival High With Lung Transplant for COVID-19-Associated ARDS
No patients demonstrated antibody-mediated rejection; all recipients alive at follow-up
Hospital Defends Decision to Deny Heart Transplant to Unvaccinated Man
Other U.S. hospitals have also faced criticism for denying transplants to patients who were not vaccinated against COVID-19
~7 Percent of Lung Transplants Due to COVID-19 Respiratory Failure
Three-month survival 95.6 percent among patients who underwent lung transplant during August 2020 to September 2021
Fourth Vaccine Dose May Up COVID-19 Immunity in Kidney Transplant Recipients
Fourth dose of mRNA vaccine increased antispike IgG titers in some kidney transplant recipients with weak serologic response after three doses
Vaccinated Kidney Transplant Recipients Vulnerable to SARS-CoV-2 Variants
After two-dose vaccination, only 64 and 67 percent of kidney transplant recipients showed neutralization against B.1.351 (β) and B.1.617.2 (δ)